HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew Cooney Selected Research

Matthew Cooney Research Topics

Disease

6Prostatic Neoplasms (Prostate Cancer)
01/2019 - 09/2012
2Neoplasms (Cancer)
09/2012 - 06/2002
1Fatigue
01/2019
1Disease Progression
06/2007
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2007
1Anaplastic Thyroid Carcinoma
06/2002

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2019 - 09/2012
2Prostate-Specific Antigen (Semenogelase)IBA
01/2018 - 09/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
01/2019
1TOR Serine-Threonine KinasesIBA
01/2019
1Bevacizumab (Avastin)FDA Link
01/2019
1temsirolimusFDA Link
01/2019
1Ketoconazole (Nizoral)FDA LinkGeneric
12/2018
1Lenalidomide (CC 5013)FDA Link
12/2018
1Somatomedin Receptors (Somatomedin Receptor)IBA
01/2018
1Docetaxel (Taxotere)FDA Link
01/2018
1Insulin-Like PeptidesIBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2018
1AndrogensIBA
01/2018
1Hormones (Hormone)IBA
01/2018
13- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
01/2018
1alpha-methylacyl-CoA racemaseIBA
09/2012
1Thalidomide (Thalomid)FDA Link
06/2007
1Phosphates (Orthophosphate)IBA
06/2002
1Cell Adhesion MoleculesIBA
06/2002
1fosbretabulin (combretastatin A4)IBA
06/2002

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2019 - 06/2007
3Castration
01/2019 - 01/2018
2Therapeutics
01/2018 - 06/2007
1Radiotherapy
01/2019
1Aftercare (After-Treatment)
06/2002